Open House Contracts For Several Active Ingredients/Combinations Of Active Ingredients. The Subject Of This Publication Is The Conclusion Of Contracts In Accordance With Section 130A Paragraph 8 Sgb V For The Following Active Ingredients/Combinations Of Active Ingredients As Part Of A So-Called Openhouse Procedure: Interferon Beta 1A For Subcutaneous Use (L03ab07) Interferon Beta 1A For Intramuscular Use (L03ab07) Ponesimod (L04aa50) Sapropterin (A16ax07) Cyclosporine (L04ad01) Tamoxifen (L02ba01) Tocilizumab (L04ac07) Sofosbuvir & Velpatasvir (J05ax69) Subject To Uniform Contractual Conditions And A Uniform Access Procedure, All Suitable And Interested Pharmaceutical Companies Or Groups Of Pharmaceutical Companies Are Offered The Possibility Of Concluding A Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredients/Active Ingredient Combinations Mentioned. The Earliest Contract Start Date Is November 1St, 2023. Based On This, The Contract Term Is A Maximum Of 24 Months.
Dear Sir,
Warm Greetings from TenderDetail.com !!
We have received Tender Document request for the TDR No : 70223541
Tender Notice along with it's Attachments ( Tender Document / Scan Image of News Paper)
sent to your Email Address :.
Please check your email for Tender Document.
